SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 84 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2015. The put-call ratio across all filers is 1.53 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 100 | -99.9% | 0.00% | – |
| Q4 2015 | $24,000 | -79.7% | 69,600 | +3.0% | 0.00% | -100.0% |
| Q3 2015 | $118,000 | -16.9% | 67,600 | +6.3% | 0.00% | -50.0% |
| Q2 2015 | $142,000 | +43.4% | 63,600 | +24.5% | 0.00% | +100.0% |
| Q1 2015 | $99,000 | -32.2% | 51,100 | -8.9% | 0.00% | -50.0% |
| Q4 2014 | $146,000 | -20.7% | 56,100 | -8.2% | 0.00% | 0.0% |
| Q3 2014 | $184,000 | -16.0% | 61,100 | +14.0% | 0.00% | -33.3% |
| Q2 2014 | $219,000 | +5.8% | 53,600 | +11.4% | 0.00% | 0.0% |
| Q1 2014 | $207,000 | -13.4% | 48,100 | +2.1% | 0.00% | -25.0% |
| Q4 2013 | $239,000 | -2.0% | 47,100 | +22.0% | 0.00% | 0.0% |
| Q3 2013 | $244,000 | – | 38,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,069,140 | $64,500,000 | 87.00% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $3,480,000 | 1.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 432,259 | $752,000 | 0.28% |
| Geller Advisors LLC | 187,323 | $326,000 | 0.21% |
| CAXTON CORP | 57,000 | $99,000 | 0.13% |
| Verity Asset Management, Inc. | 64,476 | $112,000 | 0.11% |
| TFS CAPITAL LLC | 367,364 | $639,000 | 0.06% |
| Cutler Capital Management, LLC | 72,500 | $126,000 | 0.06% |
| LUCAS CAPITAL MANAGEMENT | 21,100 | $37,000 | 0.02% |
| Nine Chapters Capital Management LLC | 129,700 | $226,000 | 0.02% |